These results do indicate that altered PDK1 expression via specific targeting of PDK1 was sufficient to deactivate the PI3K/AKT/mTOR oncogenic signaling in HCC cells and sensitized the aggressive cells to IR. The gene discussed is PDK1; the disease is hepatocellular carcinoma.